Novavax Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Hello. Good morning, and welcome to the Cantor Global Healthcare Conference for 2021. My name is Charles Duncan. I'm a Managing Director and Senior Biotechnology Analyst with the firm's equity research department.
And today is day 3 of the annual conference. And I have to say, wow, what a year it has been since we've last hosted our clients in the fall of 2020.
So it's a pleasure to introduce the next presenting company that is Novavax. And with me today, I have Greg Glenn, the Chief Guru or Vaccine Guru, actually the Vice President of R&D. Greg, good morning. Good to see you.
Good morning, Charles.
And I also have John Trizzino, the company's Chief Commercial Officer, who actually used to be the Chief Financial Officer as well. John, nice to see you.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |